BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36112698)

  • 1. MEX3C-Mediated Decay of SOCS3 mRNA Promotes JAK2/STAT3 Signaling to Facilitate Metastasis in Hepatocellular Carcinoma.
    Xiao Y; Li Y; Shi D; Wang X; Dai S; Yang M; Kong L; Chen B; Huang X; Lin C; Liao W; Xu B; Chen X; Wang L; Chen X; Ouyang Y; Liu G; Li H; Song L
    Cancer Res; 2022 Nov; 82(22):4191-4205. PubMed ID: 36112698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo and in vitro effects of microRNA-221 on hepatocellular carcinoma development and progression through the JAK-STAT3 signaling pathway by targeting SOCS3.
    Huang S; Zhou D; Li YX; Ming ZY; Li KZ; Wu GB; Chen C; Zhao YN
    J Cell Physiol; 2019 Apr; 234(4):3500-3514. PubMed ID: 30370582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of FXR modulates SOCS3/Jak2/STAT3 signaling axis in a NASH-dependent hepatocellular carcinoma animal model.
    Attia YM; Tawfiq RA; Gibriel AA; Ali AA; Kassem DH; Hammam OA; Elmazar MM
    Biochem Pharmacol; 2021 Apr; 186():114497. PubMed ID: 33675775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. m
    Wu R; Liu Y; Zhao Y; Bi Z; Yao Y; Liu Q; Wang F; Wang Y; Wang X
    Cell Death Dis; 2019 Feb; 10(3):171. PubMed ID: 30787270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. METTL3 facilitates stemness properties and tumorigenicity of cancer stem cells in hepatocellular carcinoma through the SOCS3/JAK2/STAT3 signaling pathway.
    Hu J; Chen K; Hong F; Gao G; Dai X; Yin H
    Cancer Gene Ther; 2024 Feb; 31(2):228-236. PubMed ID: 38030810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long Noncoding RNA HOST2 Promotes Epithelial-Mesenchymal Transition, Proliferation, Invasion and Migration of Hepatocellular Carcinoma Cells by Activating the JAK2-STAT3 Signaling Pathway.
    Wu Y; Yuan T; Wang WW; Ge PL; Gao ZQ; Zhang G; Tang Z; Dang XW; Zhao YF; Zhang JY; Jiang GZ
    Cell Physiol Biochem; 2018; 51(1):301-314. PubMed ID: 30453302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CircSOD2 induced epigenetic alteration drives hepatocellular carcinoma progression through activating JAK2/STAT3 signaling pathway.
    Zhao Z; Song J; Tang B; Fang S; Zhang D; Zheng L; Wu F; Gao Y; Chen C; Hu X; Weng Q; Yang Y; Tu J; Ji J
    J Exp Clin Cancer Res; 2020 Nov; 39(1):259. PubMed ID: 33234142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circ_0072088 promotes progression of hepatocellular carcinoma by activating JAK2/STAT3 signaling pathway via miR-375.
    Li L; Xiao C; He K; Xiang G
    IUBMB Life; 2021 Sep; 73(9):1153-1165. PubMed ID: 34148288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effects of suppressor of cytokine signaling 3 on inflammatory cytokine expression and migration and proliferation of IL-6/IFN-γ-induced vascular smooth muscle cells.
    Xiang S; Dong NG; Liu JP; Wang Y; Shi JW; Wei ZJ; Hu XJ; Gong L
    J Huazhong Univ Sci Technolog Med Sci; 2013 Oct; 33(5):615-622. PubMed ID: 24142708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SOCS3 Silencing Promotes Activation of Vocal Fold Fibroblasts via JAK2/STAT3 Signaling Pathway.
    Li X; Hu R; Wang H; Xu W
    Inflammation; 2023 Aug; 46(4):1318-1331. PubMed ID: 37154979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II induces angiogenic factors production partly via AT1/JAK2/STAT3/SOCS3 signaling pathway in MHCC97H cells.
    Ji Y; Wang Z; Li Z; Li K; Le X; Zhang T
    Cell Physiol Biochem; 2012; 29(5-6):863-74. PubMed ID: 22613986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of SOCS3 in the liver promotes fibrosis by enhancing STAT3-mediated TGF-beta1 production.
    Ogata H; Chinen T; Yoshida T; Kinjyo I; Takaesu G; Shiraishi H; Iida M; Kobayashi T; Yoshimura A
    Oncogene; 2006 Apr; 25(17):2520-30. PubMed ID: 16474852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone deacetylases inhibitor sodium butyrate inhibits JAK2/STAT signaling through upregulation of SOCS1 and SOCS3 mediated by HDAC8 inhibition in myeloproliferative neoplasms.
    Gao SM; Chen CQ; Wang LY; Hong LL; Wu JB; Dong PH; Yu FJ
    Exp Hematol; 2013 Mar; 41(3):261-70.e4. PubMed ID: 23111066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MPT0B098, a Microtubule Inhibitor, Suppresses JAK2/STAT3 Signaling Pathway through Modulation of SOCS3 Stability in Oral Squamous Cell Carcinoma.
    Peng HY; Cheng YC; Hsu YM; Wu GH; Kuo CC; Liou JP; Chang JY; Jin SL; Shiah SG
    PLoS One; 2016; 11(7):e0158440. PubMed ID: 27367272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of chicken leptin recptor short hairpin RNA on expression of JAK2, STAT3, SOCS3 and CPT1 genes in chicken preadipocytes.
    Ban Q; Hui W; Cheng F; Liu D; Liu X
    Anim Sci J; 2017 Mar; 88(3):559-564. PubMed ID: 27868312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and prognostic value of HER-2/neu, STAT3 and SOCS3 in hepatocellular carcinoma.
    Jiang LH; Hao YL; Zhu JW
    Clin Res Hepatol Gastroenterol; 2019 Jun; 43(3):282-291. PubMed ID: 30385249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nrf2 induces lipocyte phenotype via a SOCS3-dependent negative feedback loop on JAK2/STAT3 signaling in hepatic stellate cells.
    Lu C; Xu W; Shao J; Zhang F; Chen A; Zheng S
    Int Immunopharmacol; 2017 Aug; 49():203-211. PubMed ID: 28601022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-203 regulates JAK-STAT pathway in affecting pancreatic cancer cells proliferation and apoptosis by targeting SOCS3.
    Lin XM; Chen H; Zhan XL
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6906-6913. PubMed ID: 31486490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA FEZF1-AS1 promotes cell invasion and epithelial-mesenchymal transition through JAK2/STAT3 signaling pathway in human hepatocellular carcinoma.
    Wang YD; Sun XJ; Yin JJ; Yin M; Wang W; Nie ZQ; Xu J
    Biomed Pharmacother; 2018 Oct; 106():134-141. PubMed ID: 29957463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. JAK2, STAT3 and SOCS3 gene expression in women with and without breast cancer.
    Santillán-Benítez JG; Mendieta-Zerón H; Gómez-Oliván LM; Ordóñez Quiroz A; Torres-Juárez JJ; González-Bañales JM
    Gene; 2014 Aug; 547(1):70-6. PubMed ID: 24932998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.